Cargando…

Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study

BACKGROUND: Drug-induced and drug-related deaths have been increasing for the past decade throughout the US. In NYC, drug overdose accounts for nearly 900 deaths per year, a figure that exceeds the number of deaths each year from homicide. Naloxone, a highly effective opiate antagonist, has for deca...

Descripción completa

Detalles Bibliográficos
Autores principales: Worthington, Nancy, Markham Piper, Tinka, Galea, Sandro, Rosenthal, David
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557479/
https://www.ncbi.nlm.nih.gov/pubmed/16822302
http://dx.doi.org/10.1186/1477-7517-3-19
_version_ 1782129374094426112
author Worthington, Nancy
Markham Piper, Tinka
Galea, Sandro
Rosenthal, David
author_facet Worthington, Nancy
Markham Piper, Tinka
Galea, Sandro
Rosenthal, David
author_sort Worthington, Nancy
collection PubMed
description BACKGROUND: Drug-induced and drug-related deaths have been increasing for the past decade throughout the US. In NYC, drug overdose accounts for nearly 900 deaths per year, a figure that exceeds the number of deaths each year from homicide. Naloxone, a highly effective opiate antagonist, has for decades been used by doctors and paramedics during emergency resuscitation after an opiate overdose. Following the lead of programs in Europe and the US who have successfully distributed take-home naloxone, the Overdose Prevention and Reversal Program at the Lower East Side Harm Reduction Center (LESHRC) has started providing a similar resource for opiate users in NYC. Participants in the program receive a prescription for two doses of naloxone, with refills as needed, and comprehensive training to reduce overdose risk, administer naloxone, perform rescue breathing, and call 911. As of September 2005, 204 participants have received naloxone and been trained, and 40 have revived an overdosing friend or family member. While naloxone accessibility stands as a proven life-saving measure, some opiates users at LESHRC have expressed only minimal interest in naloxone use, due to past experiences and common misconceptions. METHODS: In order to improve the naloxone distribution program two focus groups were conducted in December 2004 with 13 opiate users at LESHRC to examine knowledge about overdose and overdose prevention. The focus groups assessed participants' (i) experiences with overdose response, specifically naloxone (ii) understanding and perceptions of naloxone, (iii) comfort level with naloxone administration and (iv) feedback about increasing the visibility and desirability of the naloxone distribution program. RESULTS: Analyses suggest that there is both support for and resistance to take-home naloxone, marked by enthusiasm for its potential role in reviving an overdosing individual, numerous misconceptions and negative views of its impact and use. CONCLUSION: Focus group results will be used to increase participation in the program and reshape perceptions about naloxone among opiate users, also targeting those already prescribed naloxone to increase their comfort using it. Since NYC is advancing toward a citywide naloxone distribution program, the LESHRC program will play an important role in establishing protocol for effective and wide-reaching naloxone availability.
format Text
id pubmed-1557479
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15574792006-08-30 Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study Worthington, Nancy Markham Piper, Tinka Galea, Sandro Rosenthal, David Harm Reduct J Research BACKGROUND: Drug-induced and drug-related deaths have been increasing for the past decade throughout the US. In NYC, drug overdose accounts for nearly 900 deaths per year, a figure that exceeds the number of deaths each year from homicide. Naloxone, a highly effective opiate antagonist, has for decades been used by doctors and paramedics during emergency resuscitation after an opiate overdose. Following the lead of programs in Europe and the US who have successfully distributed take-home naloxone, the Overdose Prevention and Reversal Program at the Lower East Side Harm Reduction Center (LESHRC) has started providing a similar resource for opiate users in NYC. Participants in the program receive a prescription for two doses of naloxone, with refills as needed, and comprehensive training to reduce overdose risk, administer naloxone, perform rescue breathing, and call 911. As of September 2005, 204 participants have received naloxone and been trained, and 40 have revived an overdosing friend or family member. While naloxone accessibility stands as a proven life-saving measure, some opiates users at LESHRC have expressed only minimal interest in naloxone use, due to past experiences and common misconceptions. METHODS: In order to improve the naloxone distribution program two focus groups were conducted in December 2004 with 13 opiate users at LESHRC to examine knowledge about overdose and overdose prevention. The focus groups assessed participants' (i) experiences with overdose response, specifically naloxone (ii) understanding and perceptions of naloxone, (iii) comfort level with naloxone administration and (iv) feedback about increasing the visibility and desirability of the naloxone distribution program. RESULTS: Analyses suggest that there is both support for and resistance to take-home naloxone, marked by enthusiasm for its potential role in reviving an overdosing individual, numerous misconceptions and negative views of its impact and use. CONCLUSION: Focus group results will be used to increase participation in the program and reshape perceptions about naloxone among opiate users, also targeting those already prescribed naloxone to increase their comfort using it. Since NYC is advancing toward a citywide naloxone distribution program, the LESHRC program will play an important role in establishing protocol for effective and wide-reaching naloxone availability. BioMed Central 2006-07-05 /pmc/articles/PMC1557479/ /pubmed/16822302 http://dx.doi.org/10.1186/1477-7517-3-19 Text en Copyright © 2006 Worthington et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Worthington, Nancy
Markham Piper, Tinka
Galea, Sandro
Rosenthal, David
Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study
title Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study
title_full Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study
title_fullStr Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study
title_full_unstemmed Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study
title_short Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study
title_sort opiate users' knowledge about overdose prevention and naloxone in new york city: a focus group study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1557479/
https://www.ncbi.nlm.nih.gov/pubmed/16822302
http://dx.doi.org/10.1186/1477-7517-3-19
work_keys_str_mv AT worthingtonnancy opiateusersknowledgeaboutoverdosepreventionandnaloxoneinnewyorkcityafocusgroupstudy
AT markhampipertinka opiateusersknowledgeaboutoverdosepreventionandnaloxoneinnewyorkcityafocusgroupstudy
AT galeasandro opiateusersknowledgeaboutoverdosepreventionandnaloxoneinnewyorkcityafocusgroupstudy
AT rosenthaldavid opiateusersknowledgeaboutoverdosepreventionandnaloxoneinnewyorkcityafocusgroupstudy